Yahoo
NSE - Free Realtime Quote INR

Pfizer Limited (PFIZER.NS)

3,830.80 +192.10 (+5.29%)
As of 2:49:41 PM GMT+5:30. Market Open.
Chart Range Bar
Loading chart for PFIZER.NS
  • Previous Close 3,638.70
  • Open 3,670.00
  • Bid 3,707.10 x --
  • Ask 3,704.80 x --
  • Day's Range 3,633.10 - 3,848.00
  • 52 Week Range 3,589.00 - 5,339.00
  • Volume 43,884
  • Avg. Volume 47,669
  • Market Cap (intraday) 175.25B
  • Beta (5Y Monthly) 0.16
  • PE Ratio (TTM) 22.73
  • EPS (TTM) 162.87
  • Earnings Date Nov 3, 2026
  • Forward Dividend & Yield 75.00 (2.06%)
  • Ex-Dividend Date Jul 17, 2026
  • 1y Target Est 6,008.50

Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally. It offers therapy area and products, such as vaccines, injectables and anti-infectives, inflammation and immunology, and internal medicine for cardiovascular care, oncology, respiratory, multivitamins and multimineral, neuroscience, women's health, gastroenterology, pain management, and nutrition, addressing. The company also offers anti-infectives services to hospitals and nursing homes. It sells its products through a network of independent distributors. Pfizer Limited was incorporated in 1950 and is based in Mumbai, India.

www.pfizerltd.co.in

1,244

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/3/2026, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

PFIZER.NS
24.57%
S&P BSE SENSEX (^BSESN)
10.26%

1-Year Return

PFIZER.NS
27.39%
S&P BSE SENSEX (^BSESN)
8.93%

3-Year Return

PFIZER.NS
0.22%
S&P BSE SENSEX (^BSESN)
18.82%

5-Year Return

PFIZER.NS
20.43%
S&P BSE SENSEX (^BSESN)
27.95%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY27
Revenue 6.53B
Earnings --
Profit Margin 0.00%

Q1

FY26

Q2

FY26

Q3

FY26

Q1

FY27

0
2B
4B
6B
0.0%
10.0%
20.0%

Analyst Insights

View More

Analyst Price Targets

4,900.00
6,008.50 Average
3,830.80 Current
7,319.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    28.61%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    25.7B

  • Net Income Avi to Common (ttm)

    7.35B

  • Diluted EPS (ttm)

    162.87

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    30.88B

  • Total Debt/Equity (mrq)

    1.67%

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: